Heratizadeh, A.; Haufe, E.; Stoelzl, D. et al.
Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermanyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2020
Bednarczyk, Monika; Stege, Henner; Grabbe, Stephan et al.
beta 2 Integrins-Multi-Functional Leukocyte Receptors in Health and DiseaseINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 21. H. 4. 2020
Frey, Marie-Luise; Simon, Johanna; Brueckner, Maximilian et al.
Bio-orthogonal triazolinedione (TAD) crosslinked protein nanocapsules affect protein adsorption and cell interactionPOLYMER CHEMISTRY. Bd. 11. H. 23. 2020 S. 3821-3830
Wang, Shunfeng; Wang, Xiaohong; Neufurth, Meik et al.
Biomimetic Alginate/Gelatin Cross-Linked Hydrogels Supplemented with Polyphosphate for Wound Healing ApplicationsMOLECULES. Bd. 25. H. 21. 2020
Thiramanas, Raweewan; Li, Mengyi; Jiang, Shuai et al.
Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell FunctionsCELLS. Bd. 9. H. 9. 2020
Kocaturk, E.; Al-Ahmad, M.; Krause, K. et al.
Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE projectALLERGY. Bd. 75. 2020 S. 83-84
Sommer, Rachel; Da Silva, Neuza; Langenbruch, Anna et al.
Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticariaEUROPEAN JOURNAL OF DERMATOLOGY. Bd. 30. H. 3. 2020 S. 259-266
Gabrielli, Sofianne; Le, Michelle; Netchiporouk, Elena et al.
Chronic urticaria in children can be controlled effectively with updosing second-generation antihistaminesJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. Bd. 82. H. 6. 2020 S. 1535-1537
Ose, Robert; Tu, Jessica; Schink, Anne et al.
Cinnamon extract inhibits allergen-specific immune responses in human and murine allergy modelsCLINICAL AND EXPERIMENTAL ALLERGY. Bd. 50. H. 1. 2020 S. 41-50
Altrichter, Sabine; Staubach, Petra; Pasha, Malika et al.
Clinical Activity of AK002, an Anti-Siglec-8 Monoclonal Antibody, in Treatment-Refractory Chronic UrticariaJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 145. H. 2. 2020 S. AB239-AB239